未登录 分享 收藏
Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial Vaduganathan, Muthiah; Inzucchi, Silvio E.; Sattar, Naveed; Fitchett, David H.; Ofstad, Anne Pernille; Brueckmann, Martina; George, Jyothis T.; Verma, Subodh; Mattheus, Michaela; Wanner, Christoph; Zinman, Bernard; Butler, Javed 分享 收藏
Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial Fitchett, David; Inzucchi, Silvio E.; Zinman, Bernard; Wanner, Christoph; Schumacher, Martin; Schmoor, Claudia; Ohneberg, Kristin; Ofstad, Anne Pernille; Salsali, Afshin; George, Jyothis T.; Hantel, Stefan; Bluhmki, Erich; Lachin, John M.; Zannad, Faiez 分享 收藏
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial (vol 14,pg 226, 2021) Wanner, Christoph; Cooper, Mark E.; Johansen, Odd Erik; Toto, Robert; Rosenstock, Julio; McGuire, Darren K.; Kahn, Steven E.; Pfarr, Egon; Schnaidt, Sven; von Eynatten, Maximilian; George, Jyothis T.; Gollop, Nicholas D.; Marx, Nikolaus; Alexander, John H.; Zinman, Bernard; Perkovic, Vlado 分享 收藏
Use of diuretics and outcomes in patients with type 2 diabetes: findings from the EMPA-REG OUTCOME trial Pellicori, Pierpaolo; Fitchett, David; Kosiborod, Mikhail N.; Ofstad, Anne P.; Seman, Leo; Zinman, Bernard; Zwiener, Isabella; Wanner, Christoph; George, Jyothis; Inzucchi, Silvio E.; Testani, Jeffrey M.; Cleland, John G. F. 分享 收藏
Time to cardiovascular benefits of empagliflozin: a post hoc observation from the EMPA-REG OUTCOME trial Verma, Subodh; Leiter, Lawrence A.; Zinman, Bernard; Sharma, Abhinav; Mattheus, Michaela; Fitchett, David; George, Jyothis; Ofstad, Anne Pernille; Kosiborod, Mikhail N.; Wanner, Christoph; Inzucchi, Silvio E. 分享 收藏
Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the EMPA-REG OUTCOME trial with a focus on Asia 根据体重指数，恩格列净对心肾预后和死亡率的影响: EMPA-REG OUTCOME试验的亚组分析，重点是亚洲 Ji, Qiuhe; Ji, Linong; Mu, Yiming; Zhao, Jiajun; Zinman, Bernard; Wanner, Christoph; George, Jyothis T.; Zwiener, Isabella; Ueki, Kohjiro; Yokote, Koutaro; Ogawa, Wataru; Johansen, Odd Erik 分享 收藏
Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure Hundertmark, Moritz J.; Agbaje, Olorunsola F.; Coleman, Ruth; George, Jyothis T.; Grempler, Rolf; Holman, Rury R.; Lamlum, Hanan; Lee, Jisoo; Milton, Joanne E.; Niessen, Heiko G.; Rider, Oliver; Rodgers, Christopher T.; Valkovic, Ladislav; Wicks, Eleanor; Mahmod, Masliza; Neubauer, Stefan 分享 收藏
分享 收藏
Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial Ferreira, Joao Pedro; Kraus, Bettina Johanna; Zwiener, Isabella; Lauer, Sabine; Zinman, Bernard; Fitchett, David H.; Koitka-Weber, Audrey; George, Jyothis T.; Ofstad, Anne Pernille; Wanner, Christoph; Zannad, Faiez 分享 收藏
Impact of polyvascular disease with and without co-existent kidney dysfunction on cardiovascular outcomes in diabetes: A post hoc analysis of EMPA-REG OUTCOME 伴或不伴肾功能不全的多血管疾病对糖尿病患者心血管结局的影响: EMPA-REG结局的事后分析 Verma, Subodh; Mazer, C. David; Inzucchi, Silvio E.; Wanner, Christoph; Ofstad, Anne Pernille; Johansen, Odd Erik; Zwiener, Isabella; George, Jyothis T.; Butler, Javed; Zinman, Bernard 分享 收藏
Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial Wanner, Christoph; Cooper, Mark E.; Johansen, Odd Erik; Toto, Robert; Rosenstock, Julio; McGuire, Darren K.; Kahn, Steven E.; Pfarr, Egon; Schnaidt, Sven; von Eynatten, Maximilian; George, Jyothis T.; Gollop, Nicholas D.; Marx, Nikolaus; Alexander, John H.; Zinman, Bernard; Perkovic, Vlado 分享 收藏
Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial Ferreira, Joao Pedro; Verma, Subodh; Fitchett, David; Ofstad, Anne Pernille; Lauer, Sabine; Zwiener, Isabella; George, Jyothis; Wanner, Christoph; Zinman, Bernard; Inzucchi, Silvio E. 分享 收藏
分享 收藏
Empagliflozin Reduces the Total Burden of Cardiovascular Events Including Recurrent Events in the EMPA-REG OUTCOME Trial Fitchett, David H.; Inzucchi, Silvio E.; Zinman, Bernard; Wanner, Christoph; Anker, Stefan D.; Pocock, Stuart; Kaspers, Stefan; George, Jyothis T.; Johansen, Odd Erik; Jamal, Waheed; Hantel, Stefan; Lund, Soren S. 分享 收藏
External Applicability of REDUCE-IT in a Large Diabetes Cardiovascular Outcomes Trial: A Post Hoc Analysis of EMPA-REG OUTCOME Verma, Subodh; Bhatt, Deepak L.; Leiter, Lawrence A.; Fitchett, David H.; Ofstad, Anne Pernille; Wanner, Christoph; George, Jyothis T.; Mattheus, Michaela; Zinman, Bernard; Lawler, Patrick R. 分享 收藏
Effect of Empagliflozin on Total Events of Myocardial Infarctions by Subtype in the EMPA-REG OUTCOME Trial Fitchett, David H.; Zinman, Bernard; Inzucchi, Silvio E.; Wanner, Christoph; Anker, Stefan D.; Pocock, Stuart; Kaspers, Stefan; George, Jyothis T.; Johansen, Odd Erik; Jamal, Waheed; Mattheus, Michaela; Vedin, Ola; Hantel, Stefan; Lund, Soren S. 分享 收藏
Empagliflozin's Cardiovascular Impact in High-Risk Patients With Type 2 Diabetes and Obstructive Pulmonary Disease: An Inquiry From EMPA-REG OUTCOME Anker, Stefan D.; Fitchett, David H.; Zinman, Bernard; Ofstad, Anne Pernille; Wanner, Christoph; Vedin, Ola; Schinzel, Birgit; Yaggi, Henry K.; George, Jyothis T.; Sander, Leif Erik; Inzucchi, Silvio E.; Verma, Subodh 分享 收藏
分享 收藏
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Multinational Trial Levin, Adeera; Perkovic, Vlado; Wheeler, David C.; Hantel, Stefan; George, Jyothis T.; von Eynatten, Maximilian; Koitka-Weber, Audrey; Wanner, Christoph 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
